HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.

Abstract
Thrombotic complications constitute an important risk in transplant recipients, in whom a hypercoagulable state and hypofibrinolysis have been associated with immunosuppressive treatment, especially with cyclosporine. In no case have clotting and fibrinolytic abnormalities been correlated with steroid immunosuppression, even though steroids were always administered. Previous studies found a relationship between hypercorticism and hypofibrinolysis both in Cushing's disease and after renal transplantation. The aim of this investigation was to compare fibrinolytic potential using the venous occlusion test in two similar groups of heart transplant patients treated with or without steroids. Euglobulin lysis time, tissue-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) activities, and antigens were determined before and after the venous occlusion test. A reduced fibrinolytic potential (significant prolongation of lysis time) due to a significant increase in PAI-1 activity and antigen levels was found in heart transplant patients treated with steroids, as compared with patients without steroid treatment and control subjects. The prevalence of reduced fibrinolytic potential was 69.2% (18 cases) in the steroid-treated group and 34.8% (8 cases) in the non-steroid-treated group. In every case, the impaired fibrinolytic potential was due to high basal PAI-1 levels. Our results are compatible with the presence of a hypofibrinolytic state secondary to long-term steroid treatment. In heart transplant recipients, steroid-induced hypofibrinolysis may constitute a further risk factor for thrombotic disease.
AuthorsG M Patrassi, M T Sartori, U Livi, A Casonato, C Danesin, S Vettore, A Girolami
JournalTransplantation (Transplantation) Vol. 64 Issue 11 Pg. 1610-4 (Dec 15 1997) ISSN: 0041-1337 [Print] United States
PMID9415568 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Plasminogen Activator Inhibitor 1
  • Cyclosporine
  • Tissue Plasminogen Activator
  • Azathioprine
  • Prednisone
Topics
  • Adolescent
  • Adult
  • Aged
  • Azathioprine (therapeutic use)
  • Cyclosporine (therapeutic use)
  • Female
  • Fibrinolysis (drug effects)
  • Heart Transplantation
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 (analysis)
  • Prednisone (therapeutic use)
  • Tissue Plasminogen Activator (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: